Gut Bacteria and Inflammation in HIV and Heavy Drinking
Part of Immune system & allergy, Infections, Mental health clinical trials.
This study looks at how gut bacteria and inflammation interact in people with both HIV and heavy alcohol use. It aims to find new ways to improve health by understanding these connections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 to 75 years old and have HIV.
- Your HIV is well-controlled on the same medications for at least 6 months, and you have never taken AZT or D4T.
- You drink heavily (men: 4+ drinks often, women: 3+ drinks often).
- Your BMI is between 25 and 40.
- You are not taking antibiotics, probiotics, or certain supplements (like high-fiber or anti-inflammatory supplements) within the last 4 weeks, or you can stop them for 2 weeks before starting.
- You are not taking GLP-1 weight-loss drugs (like Ozempic) within the last 4 weeks, or you can stop them for 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of counseling and medication to help people with HIV stop smoking and cut down on heavy drinking. It aims to improve overall health and quality of life.
This study looks at the gut microbiome (the bacteria in your digestive system) in people living with HIV or hepatitis B. By comparing stool samples, researchers hope to understand how these viruses affect gut health, which might lead to better care.
This study tests whether helping men with HIV who also drink heavily can lower their alcohol use and improve how well HIV treatment works to prevent passing the virus to others. It's for men living in fishing communities in Uganda.
This study looks at ways to help people with HIV reduce the chance of heavy drinking coming back after a period of lower-risk drinking. It will use regular patient-reported check-ins about alcohol use to understand relapse patterns and test the approach’s impact.
This Phase 2 trial studies whether a probiotic (LGG) can improve health in people with alcohol use disorder and alcohol-related liver injury. It’s not an alcohol treatment study, so participants are mainly joining to see how the supplement affects the body and liver-related outcomes.
This Phase 2 study looks at how “microbiome metabolites” (chemicals from gut bacteria) and alcohol may affect heart and blood vessel risk in people living with HIV. If you qualify, you may be asked to follow a study plan to see how these factors change health markers related to cardiovascular disease.
Hear when a new Alcohol Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.